Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Epistaxis in a kidney transplant recipient: an uncommon presentation of post-transplant lymphoproliferative disease.

Yap DY, Chan GC, Mok MM, Chan TM.

Nephrology (Carlton). 2013 Jul;18(7):531. doi: 10.1111/nep.12066. No abstract available.

PMID:
23577919
2.

Conservative management of post-transplant central nervous system lymphoma.

Valavoor SH, Ashraf Z, Narwal R, Ratnam S.

Int Urol Nephrol. 2013 Aug;45(4):1219-22. doi: 10.1007/s11255-012-0146-8. Epub 2012 Apr 3. Review.

PMID:
22476860
3.

Post-transplant lymphoproliferative disorder presenting as epistaxis.

Clarke JD, Stock D, Singh V.

J Laryngol Otol. 2004 Nov;118(11):906-8.

PMID:
15638984
4.

Posttransplant lymphoproliferative disorder with lung involvement in a renal transplant recipient.

Mirza EI, Mutluay R, Suyani E, Okyay GU, Akyurek N, Aki SZ, Derici U, Arinsoy T.

Exp Clin Transplant. 2011 Dec;9(6):425-8.

5.
6.

Management and outcome of liver recipients with post-transplant lymphoproliferative disease.

Glez-Chamorro A, Jimenez C, Moreno-Glez E, Glez-Pinto I, Loinaz C, Gomez R, Garcia I, Alonso O, Palma F, Grande C.

Hepatogastroenterology. 2000 Jan-Feb;47(31):211-9.

PMID:
10690611
7.

Post-transplant lymphoproliferative disorder (PTLD) presenting as painful lymphocele 12 years after a cadaveric renal transplant.

Khan MS, Ahmed S, Challacombe B, Goldsmith D, Steward M.

Int Urol Nephrol. 2008;40(2):547-50. doi: 10.1007/s11255-008-9367-2.

PMID:
18369734
8.

Pediatric transplant grand rounds.

Benfield MR, Harmon WE.

Pediatr Transplant. 1997 Aug;1(1):65-72. No abstract available.

PMID:
10084789
9.

Subacute immune response to primary EBV infection leading to post-transplant lymphoproliferative disease in a renal transplant patient.

Leaver S, Amlot P, Thuraisingham R, Norton A, Aitken C, Cavenagh JD.

Clin Lab Haematol. 2004 Oct;26(5):351-3.

PMID:
15485466
10.

Lymphoproliferative disorders after renal transplantation: role of medical imaging.

Claudon M, Kessler M, Champigneulle J, Lefevre F, Hestin D, Renoult E.

Eur Radiol. 1998;8(9):1686-93. Review.

PMID:
9866789
11.

Hepatitis C virus related lymphoproliferative disorder in a renal transplant recipient.

Aravindan AN, Moger V, Sakhuja V, Kohli HS, Varma N, Jha V.

Int Urol Nephrol. 2006;38(2):355-7.

PMID:
16868710
12.

Low viral load post-transplant lymphoproliferative disease localized within the tongue.

Henry DD, Hunger SP, Braylan RC, Dharnidharka VR.

Transpl Infect Dis. 2008 Dec;10(6):426-30. doi: 10.1111/j.1399-3062.2008.00328.x. Epub 2008 Jul 22.

PMID:
18657087
13.

Post-transplant lymphoproliferative disorders after heart or kidney transplantation at a single centre: presentation and response to treatment.

Aversa SM, Stragliotto S, Marino D, Calabrese F, Rigotti P, Marchini F, Gambino A, Feltrin G, Boso C, Canova F, Soldà C, Mazzarotto R, Burra P.

Acta Haematol. 2008;120(1):36-46. doi: 10.1159/000155234. Epub 2008 Sep 16.

PMID:
18797163
14.

EBV-associated recurrent Hodgkin's disease after renal transplantation.

Flanagan KH, Brennan DC.

Transpl Int. 2006 Apr;19(4):338-41.

15.

[Association of post-transplant lymphoproliferative disease and visceral leishmaniasis after kidney transplantation].

Bacha MM, Abderrahim E, Ounissi M, Chaouech D, Cherif M, Turki S, Rajhi H, Znaidi N, Bahloul A, Trabelsi S, Khaled S, Ben Abdallah T, Ben Maïz H, Kheder A.

Nephrol Ther. 2011 Nov;7(6):488-93. doi: 10.1016/j.nephro.2011.01.010. Epub 2011 Mar 3. French.

PMID:
21376690
16.

PET/CT staging and response evaluation of post-transplantation lymphoproliferative disease (PTLD).

Chowdhury FU, Sheerin F, Bradley KM, Gleeson FV.

Clin Nucl Med. 2009 Jun;34(6):386-7. doi: 10.1097/RLU.0b013e3181a3456a. No abstract available.

PMID:
19487854
17.

Post-transplant lymphoproliferative disorders.

Patel PR.

Clin Oncol (R Coll Radiol). 1999;11(2):118-22.

PMID:
10378638
18.

Recurrent septicemia in a renal transplant recipient.

Nejad-Gashti H, Sanavi S, Afshar R.

Saudi J Kidney Dis Transpl. 2009 May;20(3):471-3.

19.

Pediatric central nervous system posttransplant lymphoproliferative disorder.

Brennan KC, Lowe LH, Yeaney GA.

AJNR Am J Neuroradiol. 2005 Aug;26(7):1695-7.

20.

Inhibition of mTOR by sirolimus induces remission of post-transplant lymphoproliferative disorders.

Boratyńska M, Smolska D.

Transpl Int. 2008 Jun;21(6):605-8. doi: 10.1111/j.1432-2277.2008.00655.x. Epub 2008 Feb 16. No abstract available.

Supplemental Content

Support Center